JULÄINE OF SWEDEN
LIVE

Serial Number

79344191

Owner

Nordberg Medical AB

Attorney

Rachel Zacuto

Filing Date

May 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

JULÄINE OF SWEDEN Trademark

Serial Number: 79344191 • Registration: 7616531

JULÄINE OF SWEDEN is a trademark filed by Nordberg Medical AB on May 20, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Nordberg Medical AB (5 trademarks)

Hälsovägen 7
HUDDINGE , SE

Entity Type: 99

Trademark Details

Filing Date

May 20, 2022

Registration Date

December 24, 2024

Published for Opposition

October 22, 2024

Goods & Services

injectable dermal fillers; Pharmaceutical preparations in the nature of an injectable dermal filler; pharmaceutical preparations, namely, injectable poly-l-lactic acid for use in non-surgical restorative and beauty care treatment of wrinkles fine lines, folds, scars, lips, for face and body contouring, rejuvenating the skin and stimulation of collagen production; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Dermatological pharmaceutical products for use in filling out wrinkles, folds, scars, and lips, for face and body contouring, for rejuvenating the skin and for stimulation of collagen production; Dermatological pharmaceutical products, namely, biostimulatory injectable dermal filler implant; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for stimulation of collagen production; Dermatological pharmaceutical products, namely, injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable dermal implant for non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely injectable dermal implant for stimulation of collagen production

Dermatological services for treating skin conditions; beauty consultancy; beauty treatment services of the body and face; beauty care services; beauty information services; beauty therapy treatments, namely, cosmetic body care services in the nature of cosmetic skin care services, including non-surgical treatment of fine lines and wrinkles; Skin treatments, namely, the injection of dermal filling agents and neuromuscular blocking agents to reduce the appearance of facial lines and wrinkles; beauty therapy treatment services, namely, non-invasive cosmetic body care services and cosmetic face care services; beauty therapy treatment services, namely cosmetic skincare treatment services in the nature of providing an injectable dermal filler to reduce the appearance of facial fine lines; cosmetic skin care services, namely, injection of dermal filling treatment for cosmetic skin care

Medical apparatus and devices, namely, injection needles prefilled with biostimulatory injectable dermal filler implant; Medical apparatus and devices, namely, injection needles prefilled with biostimulatory injectable dermal filler implant medical device; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-llactic acid for stimulation of collagen production; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for stimulation of collagen production; medical therapy instruments in the nature of an injection needle; hypodermic injection apparatus, namely, hypodermic needles, medical syringes and disposable syringes; hypodermic syringes for injections for medical purposes; injection needles for medical use

Filing History

CORRECTION TRANSACTION RECEIVED FROM IB
Mar 5, 2026 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 27, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 10, 2025 FICS
FINAL DISPOSITION PROCESSED
Jun 9, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 24, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2024 NONP
EXPARTE APPEAL TERMINATED
Sep 16, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 13, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 13, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 13, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 13, 2024 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 13, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 13, 2024 GNFR
FINAL REFUSAL WRITTEN
Feb 13, 2024 CNFR
ASSIGNED TO EXAMINER
Jan 9, 2024 DOCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 2, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 13, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 13, 2023 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 7, 2023 TROA
REFUSAL PROCESSED BY IB
May 31, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 10, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 12, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 7, 2022 REPR